Clinical Trial Update: Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating continuous-infusion irinotecan with radiation therapy for upper gastrointestinal cancers, including pancreatic, gastric, duodenal, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Duodenal Cancer
• Gastric Cancer
• Pancreatic Cancer

Drugs mentioned

• Irinotecan (Camptosar) (Irinotecan)

Snippet

Sponsor: University of Southern California | Conditions: Pancreatic Cancer, Gastric Cancer | Phase 1 | Status: COMPLETED